5-CL-ADB-A5-CL-ADB-A (also known as MDMB-4en-PINACA, MDMB-PENINACA, MDMB-PINACA N1-pentyl-4-en isomer) is a very potent Synthetic Cannabinoid is an indazole-based. 5-CL-ADB-A is a synthetic cannabinoid receptor agonist used as an active ingredient of products sold as cannabis substitutes. 5-CL-ADB-A has no known therapeutic or medical use. In different regions, it is being used and abused for non-medical purposes. 5CL-ADB-A buy online
- Product Name: 5CL-ADB
- Cas Number: 137350-66-4
- Molecular Formula: C20H27FN2O3
- Appearance: Crystal and powder
- Application: Research purposes
- Availability: In Stock
- Packaging: Aluminum foil bag package done by an expert
- Purity: 98.8%
- Origin: China
- Minimum order: 10 Grams
- Production Capacity: 100KG/WEEK
- Transportation: Delivery done by EMS, DHL, FEDEX, UPS and TNT
5cl adb a review
While no official scientific studies have been done on 5CL-ADB-A to date, one 2018 study published in “Forensic Toxicology” compared the potency and mechanisms of several carboxamide-type synthetic cannabinoids. These compounds, like 5CL-ADB-A, have asymmetric carbon, derived from an amide moiety composed of amino acid derivatives. Since they are analogs with similar structures, it’s assumed that these compounds behave in similar ways Indeed, the study found that all such synthetic cannabinoids are agonists that act on both CB1 and CB2 cannabinoid receptors in the body’s endocannabinoid system.
This suggests they have a cannabimimetic effect and can be potentially more potent than cannabis’s psychoactive compound THC, which works by acting on these same cannabinoid receptors. The study looked at an AB-FUBINACA, EMB-FUBINACA, 5F-EMB-PINACA, APP-CHMINACA, and MDMB-FUBICA, which all have similar structures to 5CL-ADB-A, suggesting this chemical would present similar cannabimimetic effects by acting on CB1 and CB2 receptors.
Secure and discreet shipping of 5-CL-ADB-A to USA, EU, Canada, Italy, United Kingdom, Brazil, Switzerland, Australia, New Zealand, France, Germany, Japan, Russia, Mexico, Egypt, Turkey, Spain, Argentina, Poland, Morocco, Saudi Arabia, Austria, Romania, Kazakhstan, Netherlands, Belgium, Greece, Tunisia, Czech Republic, Dominican Republic, Portugal, Hungary, Israel, Bulgaria, Finland, Denmark, Slovakia, Norway, Ireland, Croatia, Armenia, Lithuania, Slovenia, Latvia, Estonia, and many other countries.